Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit

BACKGROUND: Neurological events associated with transcatheter aortic valve implantation are major contributors to morbidity and mortality. Choosing an appropriate endpoint to determine neuroprotection device efficacy is a key difficulty inhibiting the translation of the innovation from the laborator...

Descripción completa

Detalles Bibliográficos
Autores principales: Meller, Stephanie M, Baumbach, Andreas, Voros, Szilard, Mullen, Michael, Lansky, Alexandra J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029193/
https://www.ncbi.nlm.nih.gov/pubmed/24330754
http://dx.doi.org/10.1186/1741-7015-11-257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029193/
https://www.ncbi.nlm.nih.gov/pubmed/24330754
http://dx.doi.org/10.1186/1741-7015-11-257

Ejemplares similares